In times of high uncertainty like this 2020 year, it is necessary to celebrate and savor the victories. We want to congratulate our portfolio company Sleepiz for its well-deserved success in winning collaboration with one of the three Executive MBA cohorts at the beginning of 2021
Our portfolio company ASPIVIX SA announced last week the completion of and interim analysis results from its Phase I first-in-women trial. The two-phase ADVANCE Women trial is assessing the usability, efficacy, and safety of the investigational CAREVIX, the innovative device designed as a modern and gentler alternative. Warmest congratulations on your achievement, ASPIVIX!
Following up on our diversity series today, meet Franziska and Vanessa. From the very beginning, these two brilliant women had clear ideas about their professional careers and succeeded in everything they set out to achieve. Both originally Swiss, they are natural team players. At HEMEX, we are delighted to have them on our team. Do […]